Search

Golub, T. R., G. F. Barker, K. Stegmaier, and D. G. Gilliland. 1997. “The TEL Gene Contributes to the Pathogenesis of Myeloid and Lymphoid Leukemias by Diverse Molecular Genetic Mechanisms”. Curr Top Microbiol Immunol 220: 67-79.

Hieronymus, H., J. Lamb, K. N. Ross, X. P. Peng, C. Clement, A. Rodina, M. Nieto, et al. 2006. “Gene Expression Signature-Based Chemical Genomic Prediction Identifies a Novel Class of HSP90 Pathway Modulators”. Cancer Cell 10: 321-30.

Ikeda, S., S. W. Kong, J. Lu, E. Bisping, H. Zhang, P. D. Allen, T. R. Golub, B. Pieske, and W. T. Pu. 2007. “Altered MicroRNA Expression in Human Heart Disease”. Physiol Genomics 31: 367-73.

Kamburov, A., M. S. Lawrence, P. Polak, I. Leshchiner, K. Lage, T. R. Golub, E. S. Lander, and G. Getz. 2015. “Comprehensive Assessment of Cancer Missense Mutation Clustering in Protein Structures”. Proc Natl Acad Sci U S A 112: E5486-95.

Kumar, M. S., R. E. Pester, C. Y. Chen, K. Lane, C. Chin, J. Lu, D. G. Kirsch, T. R. Golub, and T. Jacks. 2009. “Dicer1 Functions As a Haploinsufficient Tumor Suppressor”. Genes Dev 23: 2700-4.

Lamb, J., S. Ramaswamy, H. L. Ford, B. Contreras, R. V. Martinez, F. S. Kittrell, C. A. Zahnow, N. Patterson, T. R. Golub, and M. E. Ewen. 2003. “A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer”. Cell 114: 323-34.

Lechman, E. R., B. Gentner, S. W. Ng, E. M. Schoof, P. Galen, J. A. Kennedy, S. Nucera, et al. 2016. “MiR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells”. Cancer Cell 29: 214-28.

Levine, R. L., M. Wadleigh, J. Cools, B. L. Ebert, G. Wernig, B. J. Huntly, T. J. Boggon, et al. 2005. “Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia, and Myeloid Metaplasia With Myelofibrosis”. Cancer Cell 7: 387-97.

Litichevskiy, L., R. Peckner, J. G. Abelin, J. K. Asiedu, A. L. Creech, J. F. Davis, D. Davison, et al. 2018. “A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations”. Cell Syst 6: 424-443 e7.

Loh, M. L., L. B. Silverman, M. L. Young, D. Neuberg, T. R. Golub, S. E. Sallan, and D. G. Gilliland. 1998. “Incidence of TEL/AML1 Fusion in Children With Relapsed Acute Lymphoblastic Leukemia”. Blood 92: 4792-7.